(Q37235011)

19 August 2017

1 reference

title

Efficient diagnosis of suspected functional bowel disorders (English)

1 reference

19 August 2017

0 references

2

Magnus Simrén

1 reference

19 August 2017

Jenny Gunnarsson

1

1 reference

PubMed ID

18679389

19 August 2017

language of work or name

English

0 references

publication date

1 September 2008

1 reference

Nature Reviews Gastroenterology & Hepatology

19 August 2017

1 reference

19 August 2017

5

1 reference

19 August 2017

9

1 reference

19 August 2017

498-507

1 reference

https://scigraph.springernature.com/pub.10.1038/ncpgasthep1203

19 August 2017

0 references

cites work

Irritable bowel syndrome in primary care: the patients' and doctors' views on symptoms, etiology and management

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1203

The irritable bowel syndrome: long-term prognosis and the physician-patient interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1203

The effect of a nonabsorbed oral antibiotic (rifaximin) on the symptoms of the irritable bowel syndrome: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1203

Functional findings in irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1203

American Gastroenterological Association medical position statement: irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1203

7 January 2021

AGA technical review on irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1203

7 January 2021

Guidelines on the irritable bowel syndrome: mechanisms and practical management.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1203

7 January 2021

Functional bowel disorders

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1203

7 January 2021

Organic and functional disorders in 2000 gastroenterology outpatients

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1203

7 January 2021

A comparative reappraisal of the Rome II and Rome III diagnostic criteria: are we getting closer to the 'true' prevalence of irritable bowel syndrome?

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1203

7 January 2021

Natural history of functional gastrointestinal disorders: a 12-year longitudinal population-based study

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1203

7 January 2021

Prevalence of gastrointestinal symptoms in the elderly: a population-based study

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1203

7 January 2021

Medical costs in community subjects with irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1203

7 January 2021

The presentation of irritable bowel syndrome in the context of somatization disorder

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1203

7 January 2021

Non-colonic features of irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1203

7 January 2021

Overlapping upper and lower gastrointestinal symptoms in irritable bowel syndrome patients with constipation or diarrhea

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1203

7 January 2021

Towards positive diagnosis of the irritable bowel

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1203

7 January 2021

Overlap of gastrointestinal symptom complexes in a US community

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1203

7 January 2021

Racial differences in epidemiology of irritable bowel syndrome alone, un-investigated dyspepsia alone, and "overlap syndrome" among african americans compared to Caucasians: a population-based study

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1203

7 January 2021

A prospective assessment of bowel habit in irritable bowel syndrome in women: defining an alternator

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1203

7 January 2021

Clinical patterns over time in irritable bowel syndrome: symptom instability and severity variability.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1203

7 January 2021

Natural history of gastroesophageal reflux disease and functional abdominal disorders: a population-based study

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1203

7 January 2021

The epidemiology of abdominal symptoms: prevalence and demographic characteristics in a Swedish adult population. A report from the Abdominal Symptom Study

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1203

7 January 2021

The functional gastrointestinal disorders and the Rome III process

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1203

7 January 2021

Comorbidity of irritable bowel syndrome in psychiatric patients: a review.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1203

7 January 2021

Psychopathology in irritable bowel syndrome: support for a psychophysiological model

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1203

7 January 2021

Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications?

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1203

7 January 2021

Bladder smooth muscle dysfunction in patients with irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1203

7 January 2021

More accurate diagnosis of irritable bowel syndrome by the use of 'non-colonic' symptomatology

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1203

7 January 2021

Towards a better understanding of abdominal bloating and distension in functional gastrointestinal disorders

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1203

7 January 2021

Functional abdominal pain syndrome

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1203

7 January 2021

Diagnosing irritable bowel syndrome: poor agreement between general practitioners and the Rome II criteria.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1203

7 January 2021

Splitting irritable bowel syndrome: from original Rome to Rome II criteria.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1203

7 January 2021

Irritable bowel syndrome prevalence varies enormously depending on the employed diagnostic criteria: comparison of Rome II versus previous criteria in a general population

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1203

7 January 2021

Subtyping the irritable bowel syndrome by predominant bowel habit: Rome II versus Rome III.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1203

7 January 2021

Evidence- and consensus-based practice guidelines for the diagnosis of irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1203

7 January 2021

Diagnostic yield of alarm features in irritable bowel syndrome and functional dyspepsia

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1203

7 January 2021

Utility of red flag symptom exclusions in the diagnosis of irritable bowel syndrome.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1203

7 January 2021

The Diagnostic Value of Scoring Models for Organic and Non-organic Gastrointestinal Disease, Including the Irritable-bowel Syndrome

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1203

7 January 2021

The diagnosis of IBS in primary care: consensus development using nominal group technique.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1203

7 January 2021

Irritable Bowel Syndrome–Prognosis and Diagnostic Safety

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1203

7 January 2021

Prognosis in the irritable bowel syndrome: a 5-year prospective study

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1203

7 January 2021

A simple score for the identification of patients at high risk of organic diseases of the colon in the family doctor consulting room. The Local IBS Study Group

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1203

7 January 2021

Additional investigations fail to alter the diagnosis of irritable bowel syndrome in subjects fulfilling the Rome criteria.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1203

7 January 2021

Use of surrogate markers of inflammation and Rome criteria to distinguish organic from nonorganic intestinal disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1203

7 January 2021

Discriminating IBD from IBS: comparison of the test performance of fecal markers, blood leukocytes, CRP, and IBD antibodies

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1203

7 January 2021

The utility of diagnostic tests in irritable bowel syndrome patients: a systematic review

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1203

7 January 2021

Celiac disease serology in irritable bowel syndrome and dyspepsia: a population-based case-control study.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1203

7 January 2021

Association of adult coeliac disease with irritable bowel syndrome: a case-control study in patients fulfilling ROME II criteria referred to secondary care

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1203

7 January 2021

A primary care cross-sectional study of undiagnosed adult coeliac disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1203

7 January 2021

Coeliac disease presenting with symptoms of irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1203

7 January 2021

The diagnostic accuracy of serologic tests for celiac disease: a systematic review

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1203

7 January 2021

Serological testing for coeliac disease in patients with symptoms of irritable bowel syndrome: a cost-effectiveness analysis.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1203

7 January 2021

Testing for celiac sprue in irritable bowel syndrome with predominant diarrhea: a cost-effectiveness analysis

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1203

7 January 2021

The general practitioner's approach to irritable bowel syndrome: from intention to practice

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1203

7 January 2021

Relationship of diagnostic and therapeutic delay with survival in colorectal cancer: a review

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1203

7 January 2021

Is a negative colonoscopy associated with reassurance or improved health-related quality of life in irritable bowel syndrome?

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1203

7 January 2021

Colonoscopy and SeHCAT for investigation of chronic diarrhea

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1203

7 January 2021

Flexible sigmoidoscopy plus air-contrast barium enema versus colonoscopy for evaluation of symptomatic patients without evidence of bleeding

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1203

7 January 2021

Cost-effectiveness of endoscopy in irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1203

7 January 2021

Epidemiology of cholecystectomy and irritable bowel syndrome in a UK population

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1203

7 January 2021

Irritable bowel syndrome and surgery: a multivariable analysis

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1203

7 January 2021

Idiopathic bile acid malabsorption--a review of clinical presentation, diagnosis, and response to treatment

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1203

7 January 2021

Use and abuse of hydrogen breath tests

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1203

7 January 2021

Lactose malabsorption in a population with irritable bowel syndrome: prevalence and symptoms. A case-control study

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1203

7 January 2021

Does lactose maldigestion really play a role in the irritable bowel?

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1203

7 January 2021

Self-reported milk intolerance in irritable bowel syndrome: what should we believe?

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1203

7 January 2021

Irritable bowel syndrome: is the search for lactose intolerance justified?

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1203

7 January 2021

Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1203

7 January 2021

The small intestinal bacterial overgrowth. Irritable bowel syndrome hypothesis: implications for treatment

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1203

7 January 2021

Small intestinal bacterial overgrowth in patients with irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1203

7 January 2021

Detection of bacterial overgrowth in IBS using the lactulose H2 breath test: comparison with 14C-D-xylose and healthy controls

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1203

7 January 2021

Lactulose breath testing does not discriminate patients with irritable bowel syndrome from healthy controls

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1203

7 January 2021

Antibiotics increase functional abdominal symptoms

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1203

7 January 2021

New insights into the pathogenesis and pathophysiology of irritable bowel syndrome.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1203

7 January 2021

Pathophysiology, diagnosis and current management of chronic constipation

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1203

7 January 2021

Chronic intestinal pseudo-obstruction: manifestations, natural history and management.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1203

7 January 2021

Role of visceral sensitivity in the pathophysiology of irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1203

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1203

7 January 2021

Is there a role of food allergy in irritable bowel syndrome and functional dyspepsia? A systematic review

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1203

7 January 2021

Atopic irritable bowel syndrome: a novel subgroup of irritable bowel syndrome with allergic manifestations

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1203

7 January 2021

Food-specific IgG4 antibody-guided exclusion diet improves symptoms and rectal compliance in irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1203

7 January 2021

Food elimination based on IgG antibodies in irritable bowel syndrome: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1203

7 January 2021

Discrepancies between reported food intolerance and sensitization test findings in irritable bowel syndrome patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1203

7 January 2021

Identifiers

DOI

10.1038/NCPGASTHEP1203

1 reference

19 August 2017

1 reference

PubMed ID

18679389